The current financial score of KORU Medical Systems Inc is 8.34. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 12.05M, representing a year-over-year increase of 18.15%, while its net profit experienced a year-over-year increase of 222.03%.
The current valuation score of KORU Medical Systems Inc is 7.30. Its current P/E ratio is -65.70, which is -89.70% below the recent high of -6.77 and -42.41% above the recent low of -93.57.
The current earnings forecast score of KORU Medical Systems Inc is 7.60. The average price target is 6.25, with a high of 8.00 and a low of 5.00.
The current price momentum score of KORU Medical Systems Inc is 3.51. Currently, the stock price is trading between the resistance level at 3.41 and the support level at 3.07, making it suitable for range-bound swing trading.
The current institutional shareholding score of KORU Medical Systems Inc is 5.00. The latest institutional shareholding proportion is 62.71%, representing a quarter-over-quarter increase of 9.99%. The largest institutional shareholder is James Simons, holding a total of 164.90K shares, representing 0.00% of shares outstanding, with 21.37% increase in holdings.
The current risk assessment score of KORU Medical Systems Inc is 4.41. The company's beta value is 0.43. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.